Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pelvic Organ Prolapse | 28 | 2021 | 50 | 7.870 |
Why?
|
| Urinary Incontinence, Stress | 12 | 2022 | 60 | 4.560 |
Why?
|
| Uterine Prolapse | 18 | 2021 | 29 | 3.780 |
Why?
|
| Gynecology | 11 | 2020 | 46 | 2.800 |
Why?
|
| Urology | 8 | 2021 | 31 | 2.410 |
Why?
|
| Terminology as Topic | 12 | 2017 | 141 | 2.340 |
Why?
|
| Pelvic Floor | 15 | 2021 | 21 | 2.180 |
Why?
|
| Urinary Retention | 4 | 2022 | 20 | 1.830 |
Why?
|
| Gynecologic Surgical Procedures | 9 | 2017 | 37 | 1.720 |
Why?
|
| Surgical Mesh | 7 | 2021 | 57 | 1.600 |
Why?
|
| Vagina | 6 | 2021 | 88 | 1.460 |
Why?
|
| Urinary Incontinence | 12 | 2012 | 67 | 1.430 |
Why?
|
| Suburethral Slings | 6 | 2022 | 35 | 1.380 |
Why?
|
| Urinary Bladder, Overactive | 5 | 2021 | 41 | 1.370 |
Why?
|
| Periodicals as Topic | 2 | 2022 | 158 | 1.110 |
Why?
|
| Female | 76 | 2022 | 38074 | 1.090 |
Why?
|
| Humans | 83 | 2022 | 68618 | 0.910 |
Why?
|
| Surveys and Questionnaires | 13 | 2018 | 2800 | 0.890 |
Why?
|
| Severity of Illness Index | 12 | 2021 | 1851 | 0.880 |
Why?
|
| Colposcopy | 2 | 2019 | 20 | 0.840 |
Why?
|
| Cough | 5 | 2017 | 65 | 0.830 |
Why?
|
| Urodynamics | 8 | 2020 | 43 | 0.830 |
Why?
|
| Urethra | 3 | 2012 | 56 | 0.800 |
Why?
|
| Muscarinic Antagonists | 5 | 2013 | 54 | 0.770 |
Why?
|
| Phenazopyridine | 1 | 2021 | 5 | 0.760 |
Why?
|
| Botulinum Toxins | 1 | 2021 | 18 | 0.750 |
Why?
|
| Cystoscopy | 2 | 2021 | 23 | 0.750 |
Why?
|
| Urination Disorders | 2 | 2020 | 20 | 0.750 |
Why?
|
| Posture | 2 | 2017 | 107 | 0.720 |
Why?
|
| Biological Products | 1 | 2021 | 78 | 0.720 |
Why?
|
| Middle Aged | 45 | 2021 | 21147 | 0.720 |
Why?
|
| Quality of Life | 10 | 2016 | 1515 | 0.710 |
Why?
|
| Patient Preference | 1 | 2020 | 57 | 0.690 |
Why?
|
| Obstetrics | 3 | 2016 | 44 | 0.670 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.660 |
Why?
|
| Betacoronavirus | 1 | 2020 | 116 | 0.640 |
Why?
|
| Tetrahydroisoquinolines | 2 | 2009 | 4 | 0.590 |
Why?
|
| Prospective Studies | 15 | 2021 | 3705 | 0.590 |
Why?
|
| Quinuclidines | 2 | 2009 | 10 | 0.590 |
Why?
|
| Clinical Competence | 2 | 2016 | 657 | 0.580 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 143 | 0.570 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 154 | 0.570 |
Why?
|
| Checklist | 2 | 2017 | 76 | 0.560 |
Why?
|
| Internship and Residency | 2 | 2016 | 596 | 0.550 |
Why?
|
| Pandemics | 1 | 2020 | 352 | 0.540 |
Why?
|
| Cresols | 4 | 2013 | 17 | 0.500 |
Why?
|
| Phenylpropanolamine | 4 | 2013 | 16 | 0.500 |
Why?
|
| Audiovisual Aids | 1 | 2015 | 20 | 0.490 |
Why?
|
| Benzhydryl Compounds | 4 | 2013 | 62 | 0.480 |
Why?
|
| Aged | 26 | 2021 | 14862 | 0.480 |
Why?
|
| Urologic Surgical Procedures | 5 | 2022 | 47 | 0.450 |
Why?
|
| Treatment Outcome | 12 | 2021 | 7029 | 0.450 |
Why?
|
| Patient Satisfaction | 5 | 2016 | 378 | 0.450 |
Why?
|
| Adult | 29 | 2018 | 21403 | 0.430 |
Why?
|
| Watchful Waiting | 1 | 2012 | 25 | 0.420 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2012 | 4 | 0.420 |
Why?
|
| Anesthetics, General | 1 | 2012 | 3 | 0.420 |
Why?
|
| Reproducibility of Results | 13 | 2016 | 2077 | 0.400 |
Why?
|
| Classification | 1 | 2010 | 8 | 0.370 |
Why?
|
| Retrospective Studies | 6 | 2021 | 7277 | 0.370 |
Why?
|
| Cotton Fiber | 1 | 2010 | 1 | 0.360 |
Why?
|
| Polypropylenes | 2 | 2021 | 31 | 0.320 |
Why?
|
| Language | 1 | 2009 | 120 | 0.320 |
Why?
|
| Pelvis | 2 | 2005 | 38 | 0.310 |
Why?
|
| Delivery, Obstetric | 2 | 2005 | 58 | 0.300 |
Why?
|
| Perineum | 2 | 2018 | 11 | 0.290 |
Why?
|
| Pessaries | 2 | 2020 | 4 | 0.290 |
Why?
|
| Postoperative Complications | 6 | 2022 | 1615 | 0.290 |
Why?
|
| Pelvic Floor Disorders | 2 | 2018 | 2 | 0.290 |
Why?
|
| Urination | 3 | 2022 | 19 | 0.280 |
Why?
|
| Urinary Bladder Diseases | 2 | 2004 | 26 | 0.270 |
Why?
|
| Urinary Bladder | 4 | 2022 | 108 | 0.270 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2006 | 69 | 0.260 |
Why?
|
| Faculty, Medical | 1 | 2006 | 110 | 0.260 |
Why?
|
| Defecation | 1 | 2005 | 8 | 0.250 |
Why?
|
| Rectal Prolapse | 1 | 2005 | 5 | 0.250 |
Why?
|
| Female Urogenital Diseases | 2 | 2010 | 5 | 0.250 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 4848 | 0.240 |
Why?
|
| Cesarean Section | 2 | 2005 | 101 | 0.240 |
Why?
|
| International Cooperation | 4 | 2010 | 88 | 0.230 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2021 | 468 | 0.230 |
Why?
|
| Pregnancy | 4 | 2005 | 2334 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2005 | 215 | 0.230 |
Why?
|
| Students, Medical | 1 | 2006 | 210 | 0.220 |
Why?
|
| Journal Impact Factor | 1 | 2022 | 12 | 0.210 |
Why?
|
| Genitalia, Female | 1 | 2002 | 20 | 0.210 |
Why?
|
| Pain | 2 | 2022 | 472 | 0.200 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 1753 | 0.200 |
Why?
|
| Administration, Intravesical | 1 | 2021 | 8 | 0.190 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2011 | 4 | 0.190 |
Why?
|
| Tolterodine Tartrate | 4 | 2013 | 17 | 0.190 |
Why?
|
| Transplants | 2 | 2011 | 28 | 0.190 |
Why?
|
| Vaginal Diseases | 1 | 2000 | 11 | 0.180 |
Why?
|
| Disease Progression | 2 | 2021 | 1038 | 0.180 |
Why?
|
| Burnout, Professional | 1 | 2021 | 64 | 0.180 |
Why?
|
| Administration, Oral | 1 | 2021 | 411 | 0.170 |
Why?
|
| Prostheses and Implants | 2 | 2011 | 159 | 0.170 |
Why?
|
| Cross-Sectional Studies | 6 | 2014 | 2279 | 0.170 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2022 | 106 | 0.170 |
Why?
|
| Referral and Consultation | 1 | 2021 | 383 | 0.160 |
Why?
|
| Translating | 3 | 2016 | 23 | 0.160 |
Why?
|
| Prolapse | 3 | 2005 | 7 | 0.160 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 848 | 0.160 |
Why?
|
| Mental Health | 1 | 2021 | 278 | 0.160 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2004 | 767 | 0.160 |
Why?
|
| Delayed-Action Preparations | 3 | 2010 | 120 | 0.150 |
Why?
|
| Supine Position | 1 | 2017 | 11 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2020 | 453 | 0.150 |
Why?
|
| Solifenacin Succinate | 2 | 2009 | 2 | 0.150 |
Why?
|
| Adolescent | 10 | 2018 | 8912 | 0.150 |
Why?
|
| Transducers, Pressure | 1 | 1997 | 14 | 0.150 |
Why?
|
| Fetal Monitoring | 1 | 1997 | 20 | 0.150 |
Why?
|
| Reference Values | 1 | 2018 | 579 | 0.140 |
Why?
|
| History, 21st Century | 1 | 2017 | 127 | 0.140 |
Why?
|
| Electric Stimulation Therapy | 2 | 2015 | 147 | 0.140 |
Why?
|
| Young Adult | 8 | 2018 | 5717 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2017 | 248 | 0.140 |
Why?
|
| Informed Consent | 1 | 2017 | 127 | 0.140 |
Why?
|
| Brazil | 2 | 2018 | 48 | 0.130 |
Why?
|
| Mandelic Acids | 1 | 2015 | 4 | 0.130 |
Why?
|
| Delivery of Health Care | 1 | 2000 | 445 | 0.130 |
Why?
|
| Tibial Nerve | 1 | 2015 | 10 | 0.130 |
Why?
|
| Urological Agents | 1 | 2015 | 7 | 0.130 |
Why?
|
| Physical Examination | 5 | 2015 | 152 | 0.130 |
Why?
|
| Fecal Incontinence | 2 | 2005 | 6 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 504 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2021 | 2358 | 0.130 |
Why?
|
| Urethral Diseases | 1 | 1995 | 21 | 0.130 |
Why?
|
| Lasers, Gas | 1 | 2014 | 2 | 0.120 |
Why?
|
| Rejuvenation | 1 | 2014 | 3 | 0.120 |
Why?
|
| Societies, Medical | 3 | 2010 | 403 | 0.120 |
Why?
|
| Slovakia | 2 | 2014 | 4 | 0.120 |
Why?
|
| Prevalence | 4 | 2005 | 1619 | 0.110 |
Why?
|
| Body Image | 1 | 2014 | 100 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2011 | 249 | 0.110 |
Why?
|
| South Carolina | 3 | 2006 | 2752 | 0.110 |
Why?
|
| Gravidity | 1 | 2012 | 11 | 0.110 |
Why?
|
| Menopause | 1 | 2012 | 47 | 0.100 |
Why?
|
| Parity | 1 | 2012 | 71 | 0.100 |
Why?
|
| Gynecological Examination | 1 | 2012 | 2 | 0.100 |
Why?
|
| Male | 7 | 2022 | 37321 | 0.100 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2012 | 5 | 0.100 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 442 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2012 | 38 | 0.100 |
Why?
|
| ROC Curve | 3 | 2014 | 392 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2012 | 85 | 0.100 |
Why?
|
| Iran | 1 | 2011 | 12 | 0.100 |
Why?
|
| Postoperative Period | 2 | 2022 | 238 | 0.100 |
Why?
|
| Mass Screening | 1 | 1997 | 843 | 0.090 |
Why?
|
| Prosthesis Failure | 1 | 2011 | 130 | 0.090 |
Why?
|
| Argentina | 1 | 2010 | 9 | 0.090 |
Why?
|
| Thailand | 1 | 2010 | 28 | 0.090 |
Why?
|
| Denmark | 1 | 2010 | 24 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2008 | 1553 | 0.090 |
Why?
|
| Urinary Incontinence, Urge | 1 | 2010 | 12 | 0.090 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2010 | 51 | 0.090 |
Why?
|
| Women's Health | 1 | 2010 | 148 | 0.080 |
Why?
|
| Risk Factors | 2 | 2012 | 5731 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2022 | 1465 | 0.080 |
Why?
|
| Vaginal Discharge | 1 | 2007 | 3 | 0.070 |
Why?
|
| Dyspareunia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Consensus | 3 | 2012 | 211 | 0.070 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2006 | 11 | 0.070 |
Why?
|
| Double-Blind Method | 3 | 2013 | 1738 | 0.070 |
Why?
|
| Job Description | 1 | 2005 | 23 | 0.070 |
Why?
|
| Occupations | 1 | 2005 | 27 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 3259 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 306 | 0.070 |
Why?
|
| Hospitals, University | 1 | 2006 | 169 | 0.060 |
Why?
|
| Clinical Clerkship | 1 | 2006 | 63 | 0.060 |
Why?
|
| Social Class | 1 | 2005 | 127 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2005 | 84 | 0.060 |
Why?
|
| Health Care Surveys | 1 | 2006 | 239 | 0.060 |
Why?
|
| Constipation | 1 | 2005 | 32 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2005 | 867 | 0.060 |
Why?
|
| Valsalva Maneuver | 2 | 2008 | 10 | 0.060 |
Why?
|
| Interpersonal Relations | 1 | 2006 | 209 | 0.060 |
Why?
|
| Laparoscopy | 1 | 2006 | 237 | 0.060 |
Why?
|
| Birth Weight | 1 | 2005 | 186 | 0.060 |
Why?
|
| Groin | 1 | 2003 | 11 | 0.060 |
Why?
|
| Low Back Pain | 1 | 2003 | 45 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1046 | 0.050 |
Why?
|
| Risk | 1 | 2004 | 563 | 0.050 |
Why?
|
| Sexual Dysfunction, Physiological | 2 | 2014 | 22 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2005 | 286 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 567 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2003 | 737 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 931 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1864 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 504 | 0.040 |
Why?
|
| Colposcopes | 1 | 1998 | 1 | 0.040 |
Why?
|
| Palpation | 1 | 1998 | 21 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 286 | 0.040 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 426 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 422 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 1997 | 260 | 0.030 |
Why?
|
| Poland | 1 | 2016 | 10 | 0.030 |
Why?
|
| Incidence | 1 | 2000 | 1603 | 0.030 |
Why?
|
| Psychometrics | 1 | 2018 | 514 | 0.030 |
Why?
|
| France | 1 | 2015 | 26 | 0.030 |
Why?
|
| Pressure | 1 | 1996 | 252 | 0.030 |
Why?
|
| Cosmetic Techniques | 1 | 2014 | 6 | 0.030 |
Why?
|
| Chile | 1 | 2014 | 17 | 0.030 |
Why?
|
| Observer Variation | 2 | 2011 | 330 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2014 | 54 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sexuality | 1 | 2014 | 12 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 238 | 0.030 |
Why?
|
| Traction | 1 | 2013 | 10 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 201 | 0.030 |
Why?
|
| Self Concept | 1 | 2014 | 132 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2014 | 298 | 0.030 |
Why?
|
| Anesthesia | 1 | 2013 | 120 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2011 | 131 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 83 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 83 | 0.020 |
Why?
|
| Patient Safety | 1 | 2011 | 202 | 0.020 |
Why?
|
| Gravitation | 1 | 2008 | 12 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 201 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2014 | 824 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 368 | 0.020 |
Why?
|
| Depression | 1 | 2014 | 943 | 0.020 |
Why?
|
| United States | 2 | 2011 | 7367 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2010 | 310 | 0.020 |
Why?
|
| Motor Activity | 1 | 2008 | 621 | 0.020 |
Why?
|
| Income | 1 | 2005 | 167 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2005 | 880 | 0.010 |
Why?
|
| Algorithms | 1 | 2008 | 1196 | 0.010 |
Why?
|
| Logistic Models | 1 | 2005 | 1420 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 4655 | 0.010 |
Why?
|